Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Reid

Showing results (871-880 of 983) with videos related to

Pageof 99
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1999
Renal chloride channel, CLCN5, mutations in Dent's diseaseJ P Cox, K Yamamoto, P T Christie, et al.
Journal of Medicinal Chemistry|July 19, 1996
Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitorsG R Brown, D S Clarke, A J Foubister, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis of symmetrical and unsymmetrical P1/P1' cyclic ureas as HIV protease inhibitorsM Patel, R F Kaltenbach, D A Nugiel, et al.
Scientific Reports|April 21, 2016
Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonistsVernon Seow, Junxian Lim, Adam J Cotterell, et al.
Chemmedchem|July 14, 2017
Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome InhibitorsJames R Hill, Rebecca C Coll, Nancy Sue, et al.
Optics Express|April 20, 2012
A dual-spectrometer approach to reflectance measurements under sub-optimal sky conditionsCharles M Bachmann, Marcos J Montes, Christopher E Parrish, et al.
Molecular Pharmacology|March 27, 2004
Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activityDarren R March, Lavinia M Proctor, Martin J Stoermer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 11, 2006
Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectorisKenji Inoue, Akira Sugiyama, Patrick C Reid, et al.
Nature Communications|November 22, 2013
Downsizing a human inflammatory protein to a small molecule with equal potency and functionalityRobert C Reid, Mei-Kwan Yau, Ranee Singh, et al.
Cell Reports|March 10, 2021
Phosphorylation state of the histone variant H2A.X controls human stem and progenitor cell fate decisionsLuca Orlando, Borko Tanasijevic, Mio Nakanishi, et al.
Pageof 99

Showing results (871-880 of 983) with videos related to

Sort By:
Pageof 99
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1999
Renal chloride channel, CLCN5, mutations in Dent's diseaseJ P Cox, K Yamamoto, P T Christie, et al.
Journal of Medicinal Chemistry|July 19, 1996
Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitorsG R Brown, D S Clarke, A J Foubister, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis of symmetrical and unsymmetrical P1/P1' cyclic ureas as HIV protease inhibitorsM Patel, R F Kaltenbach, D A Nugiel, et al.
Scientific Reports|April 21, 2016
Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonistsVernon Seow, Junxian Lim, Adam J Cotterell, et al.
Chemmedchem|July 14, 2017
Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome InhibitorsJames R Hill, Rebecca C Coll, Nancy Sue, et al.
Optics Express|April 20, 2012
A dual-spectrometer approach to reflectance measurements under sub-optimal sky conditionsCharles M Bachmann, Marcos J Montes, Christopher E Parrish, et al.
Molecular Pharmacology|March 27, 2004
Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activityDarren R March, Lavinia M Proctor, Martin J Stoermer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 11, 2006
Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectorisKenji Inoue, Akira Sugiyama, Patrick C Reid, et al.
Nature Communications|November 22, 2013
Downsizing a human inflammatory protein to a small molecule with equal potency and functionalityRobert C Reid, Mei-Kwan Yau, Ranee Singh, et al.
Cell Reports|March 10, 2021
Phosphorylation state of the histone variant H2A.X controls human stem and progenitor cell fate decisionsLuca Orlando, Borko Tanasijevic, Mio Nakanishi, et al.
Pageof 99